1. Home
  2. ZVRA vs PSNYW Comparison

ZVRA vs PSNYW Comparison

Compare ZVRA & PSNYW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ZVRA
  • PSNYW
  • Stock Information
  • Founded
  • ZVRA 2006
  • PSNYW 2017
  • Country
  • ZVRA United States
  • PSNYW Sweden
  • Employees
  • ZVRA N/A
  • PSNYW N/A
  • Industry
  • ZVRA Biotechnology: Pharmaceutical Preparations
  • PSNYW Auto Manufacturing
  • Sector
  • ZVRA Health Care
  • PSNYW Consumer Discretionary
  • Exchange
  • ZVRA Nasdaq
  • PSNYW Nasdaq
  • Market Cap
  • ZVRA 400.8M
  • PSNYW 362.3M
  • IPO Year
  • ZVRA 2015
  • PSNYW N/A
  • Fundamental
  • Price
  • ZVRA $8.65
  • PSNYW $0.16
  • Analyst Decision
  • ZVRA Strong Buy
  • PSNYW
  • Analyst Count
  • ZVRA 8
  • PSNYW 0
  • Target Price
  • ZVRA $22.29
  • PSNYW N/A
  • AVG Volume (30 Days)
  • ZVRA 608.4K
  • PSNYW 43.4K
  • Earning Date
  • ZVRA 05-13-2025
  • PSNYW 03-06-2025
  • Dividend Yield
  • ZVRA N/A
  • PSNYW N/A
  • EPS Growth
  • ZVRA N/A
  • PSNYW N/A
  • EPS
  • ZVRA N/A
  • PSNYW N/A
  • Revenue
  • ZVRA $40,588,000.00
  • PSNYW $2,034,261,000.00
  • Revenue This Year
  • ZVRA $276.77
  • PSNYW N/A
  • Revenue Next Year
  • ZVRA $86.15
  • PSNYW $79.49
  • P/E Ratio
  • ZVRA N/A
  • PSNYW N/A
  • Revenue Growth
  • ZVRA 46.47
  • PSNYW N/A
  • 52 Week Low
  • ZVRA $4.20
  • PSNYW $0.09
  • 52 Week High
  • ZVRA $9.76
  • PSNYW $0.61
  • Technical
  • Relative Strength Index (RSI)
  • ZVRA 59.54
  • PSNYW 45.73
  • Support Level
  • ZVRA $8.21
  • PSNYW $0.16
  • Resistance Level
  • ZVRA $8.78
  • PSNYW $0.17
  • Average True Range (ATR)
  • ZVRA 0.36
  • PSNYW 0.01
  • MACD
  • ZVRA -0.01
  • PSNYW 0.00
  • Stochastic Oscillator
  • ZVRA 73.15
  • PSNYW 17.65

About ZVRA Zevra Therapeutics Inc.

Zevra Therapeutics Inc is a rare disease company combining science, data, and patient needs to create transformational therapies for diseases with limited or no treatment options. The company's mission is to bring life-changing therapeutics to people living with rare diseases. With data-driven development and commercialization strategies, it is overcoming complex drug development challenges to make new therapies available to the rare disease community.

About PSNYW Polestar Automotive Holding UK PLC Class C-1 ADS (ADW)

Polestar Automotive Holding UK PLC operates as an electric vehicle manufacturer. It engages in designing products that are engineered to excite consumers and drive change. Polestar defines market-leading standards in design, technology, and sustainability. Polestar was established as a premium electric car brand by Volvo Cars and Geely Holdings. Polestar has produced two electric performance cars namely Polestar 1 and Polestar 2. Geographically, it derives a majority of revenue from USA.

Share on Social Networks: